The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study Koharu Loulou Chayama, Jenna Valleriani, Cara Ng, Rebecca Haines-Saah, Rielle Capler, M.-J. Milloy, Will Small, Ryan McNeil Introduction People living with HIV who use drugs commonly experience chronic pain and often use illicit opioids to manage pain. […]
Read More
Regulating Cannabis: Towards a Unified Market Including analysis of hundreds of pages of government documents, almost 1000 media articles, and interviews in the field with over 30 senior government officials, industry executives, and front-line public health representatives, together with over 800 academic references, this meticulously researched book is the definitive account of real-world cannabis […]
Read More
Medical cannabis in the UK: From principle to practice Anne Katrin Schlag, David S Baldwin, Michael Barnes, Steve Bazire, Rachel Coathup, H Valerie Curran, Rupert McShane, Lawrence D Phillips, Ilina Singh, David J Nutt Background: In the UK, medical cannabis was approved in November 2018, leading many patients to believe that the medicine would […]
Read More
Three Recent Studies Link Cannabis Use to More Exercise Three recently published studies have associated cannabis use with higher levels of physical activity. Physical activity, sedentary behaviour and cannabis use in 15,822 US adults: cross-sectional analyses from NHANES L Smith, F Sherratt, Y Barnett, C Cao, M A Tully, A Koyanagi, L Jacob, P Soysal, […]
Read More
Cannabis, Cannabinoids, and Sleep: a Review of the Literature Abstract Purpose of Review The current review aims to summarize the state of research on cannabis and sleep up to 2014 and to review in detail the literature on cannabis and specific sleep disorders from 2014 to the time of publication. Recent Findings Preliminary research into […]
Read More
UK CBD Sales Surge Research from two industry pressure groups reveals the UK cannabinoid (CBD) industry was worth £690mln in the 12 months to the end of April – up almost a third since a 2019 estimate. CBD is the non-psychoactive element derived from both marijuana and hemp plants. It is used in an […]
Read More
Duration of cannabis impairment New analysis from the Lambert Initiative defines durations of impairment after inhaled or oral THC doses. Findings raise questions about current drug-driving laws, which penalise for THC presence, not intoxication levels. A comprehensive analysis of 80 scientific studies has identified a ‘window of impairment’ of between three and 10 hours caused […]
Read More
Self-Identified Medical Cannabis Consumers Report Substituting It for Prescription Drugs Key Findings • 22% of respondents reported that medical cannabis has decreased pain (517 respondents, N=2,302).a • 39% reported that medical cannabis has improved quality of life (900 respondents, N=2,302). • 61% reported having replaced prescription opioids and benzodiazepines with medical cannabis (988 respondents, N=1,622). […]
Read More
Medical Cannabis Doctors Australia proudly supports the Greens recently tabled Bill in NSW Parliament to legalise cannabis for general adult use. While the bill is primarily aimed at ‘recreational’ cannabis consumption, the component to allow people to grow a small number of plants in their own home would greatly increase access for cannabis patients in […]
Read More
According to their site, The Australian New Zealand Clinical Trials Registry (ANZCTR) is an online register of clinical trials being undertaken in Australia, New Zealand and elsewhere. The ANZCTR includes trials from the full spectrum of therapeutic areas of pharmaceuticals, surgical procedures, preventive measures, lifestyle, devices, treatment and rehabilitation strategies and complementary therapies. At […]
Read More